Recent advances and future perspectives in the treatment of adult T-cell leukemia/lymphoma (ATL/L)UOZUMI, Kimiharu; ARIMA, Naomichi.Recent research developments in haematology (Volume 2 (2005)) = 0Haematology. 2005, pp 1-19, isbn 81-7895-184-3, 19 p.Book Chapter

Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphomaOWATARI, Satsuki; OTSUKA, Maki; UOZUMI, Kimiharu et al.International journal of hematology. 2007, Vol 85, Num 1, pp 32-35, issn 0925-5710, 4 p.Article

Vincristine exacerbates asymptomatic Charcot-Marie-Tooth disease with a novel EGR2 mutationNAKAMURA, Tomonori; HASHIGUCHI, Akihiro; SUZUKI, Shinsuke et al.Neurogenetics (Oxford. Print). 2012, Vol 13, Num 1, pp 77-82, issn 1364-6745, 6 p.Article

Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donorFUJIWARA, Hiroshi; KAWADA, Hideaki; UOZUMI, Kimiharu et al.International journal of hematology. 2005, Vol 82, Num 4, pp 357-361, issn 0925-5710, 5 p.Article

Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriersAKIMOTO, Masaki; KOZAKO, Tomohiro; UOZUMI, Kimiharu et al.Journal of medical virology. 2007, Vol 79, Num 7, pp 977-986, issn 0146-6615, 10 p.Article

Smouldering adult T-cell leukaemia/lymphoma : a follow-up study in KyushuISHITSUKA, Kenji; IKEDA, Shuichi; TAMURA, Kazuo et al.British journal of haematology. 2008, Vol 143, Num 3, pp 442-444, issn 0007-1048, 3 p.Article

Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemiaWATANABE, Mariko; OHSUGI, Takeo; OKAYAMA, Akihiko et al.Blood. 2005, Vol 106, Num 7, pp 2462-2471, issn 0006-4971, 10 p.Article

Prognostic significance of multidrug resistance protein in adult T-cell leukemiaOHNO, Nobuhito; TANI, Ayako; AKIYAMA, Shin-Ichi et al.Clinical cancer research. 2001, Vol 7, Num 10, pp 3120-3126, issn 1078-0432Article

Uncommon cases of immature-type CD56⁺ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphomaOWATARI, Satsuki; OTSUKA, Maki; TAKESHITA, Taketsugu et al.International journal of hematology. 2009, Vol 89, Num 2, pp 188-194, issn 0925-5710, 7 p.Article

Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosusAKIMOTO, Masaki; MATSUSHITA, Kakushi; SURUGA, Yukio et al.Journal of rheumatology. 2007, Vol 34, Num 9, pp 1841-1848, issn 0315-162X, 8 p.Article

Cyclosporin A inhibits HTLV-I tax expression and shows anti-tumor effects in combination with VP-16OZAKI, Atsuo; ARIMA, Naomichi; MATSUSHITA, Kakushi et al.Journal of medical virology. 2007, Vol 79, Num 12, pp 1906-1913, issn 0146-6615, 8 p.Article

Target Epitopes of HTLV-1 Recognized by Class I MHC-Restricted Cytotoxic T Lymphocytes in Patients With Myelopathy and Spastic Paraparesis and Infected Patients With Autoimmune DisordersKOZAKO, Tomohiro; AKIMOTO, Masaki; KUBOTA, Ryuji et al.Journal of medical virology. 2011, Vol 83, Num 3, pp 501-509, issn 0146-6615, 9 p.Article

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myelomaTAKAMATSU, Yasushi; SUNAMI, Kazutaka; HATA, Hiroyuki et al.International journal of hematology. 2010, Vol 92, Num 3, pp 503-509, issn 0925-5710, 7 p.Article

Human T-ceff leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in JapanIWANAGA, Masako; WATANABE, Toshiki; MOCHIZUKI, Manabu et al.Blood. 2010, Vol 116, Num 8, pp 1211-1219, issn 0006-4971, 9 p.Article

Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell LymphomaYAMAMOTO, Kazuhito; UTSUNOMIYA, Atae; NAKAMURA, Shigeo et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1591-1598, issn 0732-183X, 8 p.Article

Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavirZAHIDUNNABI DEWAN, M; UCHIHARA, Jun-Nosuke; KUBUKI, Yoko et al.Blood. 2006, Vol 107, Num 2, pp 716-724, issn 0006-4971, 9 p.Article

Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)FUKUSHIMA, Takuya; NOMURA, Shogo; UTSUNOMIYA, Atae et al.British journal of haematology. 2014, Vol 166, Num 5, pp 739-748, issn 0007-1048, 10 p.Article

Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma: a multicenter phase 2 studyTAKAMATSU, Yasushi; SUNAMI, Kazutaka; MUTA, Tsuyoshi et al.International journal of hematology. 2013, Vol 98, Num 2, pp 179-185, issn 0925-5710, 7 p.Article

Novel Cytotoxic Isolated from Jamaican Hyptis verticillata jacq Induces Apoptosis and Overcomes Multidrug ResistanceWHITE, Yohann; HAMADA, Toshiyuki; FURUKAWA, Tatsuhiko et al.Anticancer research. 2011, Vol 31, Num 12, pp 4251-4257, issn 0250-7005, 7 p.Article

A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients : Japan clinical oncology group study JCOG9203MIZOROKI, Fumi; HIROSE, Yuko; FUKUHARA, Shiro et al.International journal of hematology. 2006, Vol 83, Num 1, pp 55-62, issn 0925-5710, 8 p.Article

Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemiaOHNO, Nobuhito; TANI, Ayako; UOZUMI, Kimiharu et al.Blood. 2001, Vol 98, Num 4, pp 1160-1165, issn 0006-4971Article